Lancet Subcumes: The effectiveness of the new crown vaccine in tumor patients decreases faster, and it should be vaccinated!

*For medical professionals for reading reference

Have you inoculated?

Studies have shown that tumor patients have higher risk of onset and death after infection with COVID-19 [1].The vaccination of the new crown vaccine is an important means to prevent COVID-19 infection and reduce the incidence of related complications [2].

Because tumor patients are usually excluded by clinical trials of vaccines, in addition, such patients often hesitant to vaccination, causing lack of clear evidence to prove the benefits of vaccines to tumor patients [3].

A real -world study recently published on The Lancet · Oncology shows that the vaccination of the new crown vaccine is effective and effective for patients with tumor patients and can provide different degrees of protection for breakthrough infections.However, the effectiveness of the vaccine of tumor patients is lower than that of the general population.

Study and publish screenshots

Scan the QR code below to get more tumor cutting -edge information

- END -